Dr Reddy's, BioMarin Settles Patent Dispute Over Kuvan 100mg Tablets - 22.09.2015

BioMarin Pharmaceutical has entered into a settlement agreement with Dr Reddy's Laboratories to resolve patent litigation in the US regarding Kuvan, the former's 100mg oral tablets.

Tags : BioMarin PharmaceuticalDr Reddy's LaboratoriesKuvan 100mg Tablets

Share :